FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/07/020155 [Registered on: 12/07/2019] Trial Registered Prospectively
Last Modified On: 09/07/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   effect of shigru taila nasya and pippalyadigana vati in vataja pratishyaya (allergic rhinitis)  
Scientific Title of Study   Evaluation of shigru taila nasya and pippalyadigana vati in the management of vataja pratishyaya (allergic rhinitis)-A comparative clinical study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Renu Rao 
Designation  Associate Professor 
Affiliation  Rishika campus haridwar UAU 
Address  Dep. Of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Dep. Of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Hardwar
UTTARANCHAL
249401
India 
Phone  8077151820  
Fax    
Email  docrenuprasad@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Renu Rao 
Designation  Associate Professor 
Affiliation  Rishika campus haridwar UAU 
Address  Dep of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Dep of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Hardwar
UTTARANCHAL
249401
India 
Phone  8077151820  
Fax    
Email  docrenuprasad@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Renu Rao 
Designation  Associate Professor 
Affiliation  Rishika campus haridwar UAU 
Address  Dep of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Dep of shalakya tantra, Rishikul campus haridwar uttarakhand ayurved university
Hardwar
UTTARANCHAL
249401
India 
Phone  8077151820  
Fax    
Email  docrenuprasad@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Ayurvedic college haridwar, UAU university  
 
Primary Sponsor  
Name  Rishikul campus 
Address  Rishikul campus UAU haridwar 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Priyanka Dubey  Rishikul campus haridwar  Department of shalakya Tantra rishikul campus haridwar, OPD room no 5
Hardwar
UTTARANCHAL 
9479620644

dubepriyanka.267@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J309||Allergic rhinitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group A   Group A 20 patients,3 sitting of Marsha nasya (nasal route) with shigru taila 8drops in each nostril for 7 days each will given with a gap of 7 days in between each sitting and 2 sitting of pratimarsha nasya with shigru taila 2 drop in each nostril for 7 days in between gap of Marsha nasya will be given.  
Comparator Agent  Group B  Number of patients 20, nasya with shigru taila and pippalyadigana vati will be given. Shigru taila nasya dose and duration are same as group A and pippalyadigana vati 2 BD of 250mg twice a day will given.  
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients fullfill the diagnostic criteria based on sign and symptoms of vataja pratishyaya and allergic rhinitis
Minimum 3 recurrent attack of sign and symptoms of vataja pratishyaya and allergic rhinitis 
 
ExclusionCriteria 
Details  Patients suffering from chronic or acute sinusitis, rhinitis other than allergic rhinitis, other nasal pathology like DNS., polyp
Patients suffering from any chronic systemic disease like Dm, HTN, tuberculosis, lower respiratory tract disease
Patients who have taken any antihistaminic, mast cell stabilizer, nasal corticosteroid or any other nasal anatomic variants in nose since two weeks 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Cured 90% relief in sign and symptoms
Marked improvement 76-90%
Moderate improvement 51-75%
Mild improvement 26-59%
No improvement less than 25% 
35 days 
 
Secondary Outcome  
Outcome  TimePoints 
aggravation of symptoms   1 month 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/07/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="4"
Days="12" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   trial yet to be started 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Ayurveda is an ancient system of life. On reviewing the clinical presentation from the classical ayurvedic text the sign and system of vataja pratishayaya nearly simulate with the disease Allergic Rhinitis. The present study on shigru taila and pippalyadigana vati has been taken which has its pharmacological properties like vata kapha shamak , Anuloman, Vishaghana. In study 40 patients of vataja pratishyaya will be taken in two groups 20 patient in each on the basis of inclusion and exclusion criteria and shigru taila nasya in first A group and oral administration of pippalyadigana vati with shigru taila nasya in second B group will be given. the trial duration will be 35 days.

 
Close